March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that the first patient has been dosed in ...

Houston-based March Biosciences, launched from the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston Methodist Hospital, Texas Children’s Hospital), is dedicated to ...

Houston-based March Biosciences, launched from the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital), is dedicated to addressing ...

Investigators from Baylor College of Medicine, Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor, Houston Methodist Hospital and Texas Children's Hospital examined ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of ...

Dr. Peter Hotez, a vaccine expert from Baylor College of Medicine, said he had spoken with Dr. Marks regularly during the pandemic. “He was extraordinarily committed to using science to help the ...

Biosciences announced the first patient has been dosed in its Phase 2 trial of MB-105, a first-in-class CD5-targeted CAR-T ...

The trial will test MB-105 in up to 46 patients with relapsed or refractory CD5-positive cutaneous T-cell lymphoma or peripheral T-cell lymphoma.

Baylor College of Medicine is the STAT Madness 2025 champion! This is the second year in a row that Baylor has won the popular vote in STAT’s bracket-style research competition. This year’s winning ...

Baylor College of Medicine was recognized as a top institution for medical research, earning Tier 1 status in the U.S. News & World Report 2025 Best Graduate Schools rankings. Baylor is one of only 16 ...